Related Experiment Videos

A case of variant angina and myocardial infarction 6 months after successful bypass surgery

Japanese Heart Journal
|September 1, 1983
PubMed

Insights

Discontinuing calcium antagonists after bypass surgery for variant angina can trigger myocardial infarction due to coronary artery spasm. Continuous calcium antagonist therapy is recommended post-surgery for these patients.

Area of Science:

  • Cardiology
  • Vascular Surgery

Background:

  • Variant angina (Prinzmetal's angina) involves coronary artery spasm.
  • Coronary artery bypass grafting (CABG) is a treatment for severe coronary artery disease.
  • Calcium antagonists are used to manage vasospastic angina.

Observation:

  • A 61-year-old man with variant angina underwent successful CABG for a 90% LAD stenosis.
  • Post-surgery, the patient received continuous diltiazem (a calcium antagonist).
  • Diltiazem was discontinued 6 months post-CABG due to hepatitis.

Findings:

  • Within days of diltiazem discontinuation, the patient experienced an acute anterior myocardial infarction.
  • Angiography confirmed a patent graft but revealed an anteroapical infarction.
  • The infarction was attributed to severe, prolonged spasm of the left anterior descending artery (LAD).

Implications:

  • This case highlights the critical role of continuous calcium antagonist therapy in preventing vasospasm post-CABG in variant angina patients.
  • Abrupt cessation of calcium antagonists can precipitate myocardial infarction in susceptible individuals.
  • Long-term calcium antagonist use should be considered in patients with variant angina undergoing CABG.

Related Concept Videos